Trait centric view

1. Trait name:	Milk fat yield
   Ontology terms:	VT:1000161, LPT:0010027, CMO:0000814

   1 gene are associated with this trait, with QTL/association found

   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:101374;
   729 correlations are found involving Milk fat yield
    

2. Trait name:	Milk yield
   Ontology terms:	VT:0015043, CMO:0001306

   444 genes are associated with this trait, with QTL/association found

   • ABCA1: ATP binding cassette subfamily A member 1
     evidenced by: QTL:181815;
   • ABCA7: ATP binding cassette subfamily A member 7
     evidenced by: QTL:181818;
   • ABCG2: ATP-binding cassette, sub-family G (WHITE), member 2
     evidenced by: QTL:10486; QTL:15939; QTL:15940; QTL:168314;
   • ACACB: Acetyl-CoA carboxylase beta
     evidenced by: QTL:153260; QTL:153264; QTL:153269; QTL:153272; QTL:153277; QTL:153284; QTL:153287; QTL:153294; QTL:153298; QTL:153302; QTL:153307; QTL:153310; QTL:153313; QTL:153317; QTL:153320; QTL:153324; QTL:153327; QTL:153331; QTL:153335; QTL:153338; QTL:153343; QTL:153346; QTL:153349; QTL:153355; QTL:153361; QTL:153365; QTL:153369; QTL:153373; QTL:153378; QTL:153384; QTL:153390; QTL:153394; QTL:153397; QTL:153400; QTL:153404; QTL:153407; QTL:153410; QTL:153414; QTL:153418; QTL:153422; QTL:153426;
   • ACADVL: Acyl-CoA dehydrogenase very long chain
     evidenced by: QTL:282763; QTL:282767; QTL:282769; QTL:282774; QTL:282778; QTL:282789; QTL:282796;
   • ACAT2: Acetyl-CoA acetyltransferase 2
     evidenced by: QTL:181813;
   • ACO2: Aconitase 2, mitochondrial
     evidenced by: QTL:16163; QTL:175939;
   • ADAMTS12: ADAM metallopeptidase with thrombospondin type 1 motif 12
     evidenced by: QTL:174783;
   • ADCY3: Adenylate cyclase 3
     evidenced by: QTL:45548; QTL:45562;
   • ADGRB1: Adhesion G protein-coupled receptor B1
     evidenced by: QTL:174577; QTL:174578; QTL:174579; QTL:174580;
   • ADGRL3: Adhesion G protein-coupled receptor L3
     evidenced by: QTL:174425;
   • AFF2: AF4/FMR2 family member 2
     evidenced by: QTL:54500;
   • AGBL4: ATP/GTP binding protein like 4
     evidenced by: QTL:175933;
   • AGO2: Argonaute 2, RISC catalytic component
     evidenced by: QTL:174612; QTL:174613;
   • ALDH18A1: Aldehyde dehydrogenase 18 family member A1
     evidenced by: QTL:261670; QTL:261672; QTL:261676; QTL:261679; QTL:261682; QTL:261684; QTL:261689; QTL:261693; QTL:261698; QTL:261710; QTL:261713; QTL:261716;
   • ALDH5A1: Aldehyde dehydrogenase 5 family member A1
     evidenced by: QTL:52233;
   • ALKBH2: AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase
     evidenced by: QTL:49406;
   • ANKRD17: Ankyrin repeat domain 17
     evidenced by: QTL:42315;
   • ANKRD52: Ankyrin repeat domain 52
     evidenced by: QTL:175940;
   • ANO6: Anoctamin 6
     evidenced by: QTL:174385;
   • APP: Amyloid beta precursor protein
     evidenced by: QTL:38156;
   • ARFGEF1: ADP-ribosylation factor guanine nucleotide-exchange factor 1 (brefeldin A-inhibited)
     evidenced by: QTL:18866;
   • ARFGEF3: ARFGEF family member 3
     evidenced by: QTL:174505;
   • ARHGAP22: Rho GTPase activating protein 22
     evidenced by: QTL:53852;
   • ARHGAP26: Rho GTPase activating protein 26
     evidenced by: QTL:43081;
   • ARHGAP35: Rho GTPase activating protein 35
     evidenced by: QTL:95243;
   • ARHGAP39: Rho GTPase activating protein 39
     evidenced by: QTL:174533;
   • ARHGAP6: Rho GTPase activating protein 6
     evidenced by: QTL:55459;
   • ARID5B: AT rich interactive domain 5B (MRF1-like)
     evidenced by: QTL:16203;
   • ARL4A: ADP ribosylation factor like GTPase 4A
     evidenced by: QTL:125812; QTL:166798;
   • ARNTL: Aryl hydrocarbon receptor nuclear translocator like
     evidenced by: QTL:256247; QTL:256248; QTL:256252; QTL:256253; QTL:256256; QTL:256257; QTL:256283; QTL:256287;
   • ARRB1: Arrestin beta 1
     evidenced by: QTL:174681;
   • ARSG: Arylsulfatase G
     evidenced by: QTL:50251;
   • ASB5: Ankyrin repeat and SOCS box containing 5
     evidenced by: QTL:53319;
   • ATF3: Activating transcription factor 3
     evidenced by: QTL:135464; QTL:135467; QTL:135474; QTL:135478; QTL:135481; QTL:135487; QTL:135491; QTL:135495; QTL:135498; QTL:135501; QTL:135505; QTL:135507; QTL:135511; QTL:135514; QTL:135517; QTL:135520; QTL:135522; QTL:135525; QTL:135528; QTL:135531; QTL:135535; QTL:135539; QTL:135543; QTL:135547; QTL:135550; QTL:135553; QTL:135556; QTL:135580; QTL:135585;
   • ATF7: Activating transcription factor 7
     evidenced by: QTL:175941;
   • ATP1A1: ATPase, Na+/K+ transporting, alpha 1 polypeptide
     evidenced by: QTL:13133; QTL:13134; QTL:21105;
   • ATP1B2: ATPase, Na+/K+ transporting, beta 2 polypeptide
     evidenced by: QTL:14128; QTL:14129; QTL:14132; QTL:14133; QTL:14134;
   • ATP5MC2: ATP synthase membrane subunit c locus 2
     evidenced by: QTL:175942;
   • AURKA: Aurora kinase A
     evidenced by: QTL:47316;
   • AVP: Arginine vasopressin
     evidenced by: QTL:57239;
   • BAG2: BAG cochaperone 2
     evidenced by: QTL:51927;
   • BAIAP2: BAI1-associated protein 2
     evidenced by: QTL:125129; QTL:16259;
   • BCAR3: BCAR3 adaptor protein, NSP family member
     evidenced by: QTL:174359;
   • BCAS3: BCAS3 microtubule associated cell migration factor
     evidenced by: QTL:315277;
   • BCAT1: Branched chain amino-acid transaminase 1, cytosolic
     evidenced by: QTL:16166;
   • BCO2: Beta-carotene oxygenase 2
     evidenced by: QTL:21195;
   • BEST3: Bestrophin 3
     evidenced by: QTL:174401; QTL:40913;
   • BICRAL: BRD4 interacting chromatin remodeling complex associated protein like
     evidenced by: QTL:176056;
   • BMPR1A: Bone morphogenetic protein receptor, type IA
     evidenced by: QTL:218685;
   • BOLA-DRB3: Major histocompatibility complex, class II, DRB3
     evidenced by: QTL:3630;
   • BRINP3: Bone morphogenetic protein/retinoic acid inducible neural-specific 3
     evidenced by: QTL:57246;
   • BTN1A1: Butyrophilin, subfamily 1, member A1
     evidenced by: QTL:136281;
   • BYSL: Bystin like
     evidenced by: QTL:176052;
   • C4A: Complement component 4A
     evidenced by: QTL:19984; QTL:19988; QTL:19992;
   • C5H12ORF40: Chromosome 5 C12orf40 homolog
     evidenced by: QTL:174391;
   • C6: Complement C6
     evidenced by: QTL:174735; QTL:174736; QTL:176004;
   • C7: Complement C7
     evidenced by: QTL:174738; QTL:174739; QTL:176005; QTL:176006;
   • CACNA1D: Calcium channel, voltage-dependent, L type, alpha 1D subunit
     evidenced by: QTL:57240;
   • CACNA2D1: Calcium channel, voltage-dependent, alpha 2/delta subunit 1
     evidenced by: QTL:161389; QTL:161390; QTL:161391; QTL:161392; QTL:161393;
   • CACNG5: Calcium voltage-gated channel auxiliary subunit gamma 5
     evidenced by: QTL:50271;
   • CADM1: Cell adhesion molecule 1
     evidenced by: QTL:315282;
   • CAST: Calpastatin
     evidenced by: QTL:57241;
   • CBX6: Chromobox 6
     evidenced by: QTL:175943;
   • CCDC18: Coiled-coil domain containing 18
     evidenced by: QTL:174360;
   • CCL28: C-C motif chemokine ligand 28
     evidenced by: QTL:174716;
   • CCL2: Chemokine (C-C motif) ligand 2
     evidenced by: QTL:9936; QTL:9945;
   • CCNB1: Cyclin B1
     evidenced by: QTL:16263;
   • CCND3: Cyclin D3
     evidenced by: QTL:176053;
   • CD14: CD14 molecule
     evidenced by: QTL:14036; QTL:57242;
   • CD4: CD4 molecule
     evidenced by: QTL:14137;
   • CDH4: Cadherin 4
     evidenced by: QTL:174524; QTL:174525; QTL:174526;
   • CDH6: Cadherin 6
     evidenced by: QTL:174788;
   • CDKAL1: CDK5 regulatory subunit associated protein 1 like 1
     evidenced by: QTL:174793;
   • CDKN1A: Cyclin dependent kinase inhibitor 1A
     evidenced by: QTL:135559; QTL:135561; QTL:135565; QTL:135566; QTL:135572; QTL:135576; QTL:135590;
   • CENPC: Centromere protein C
     evidenced by: QTL:174439; QTL:174440;
   • CENPE: Centromere protein E
     evidenced by: QTL:172732; QTL:172738; QTL:172741; QTL:172759;
   • CEP63: Centrosomal protein 63
     evidenced by: QTL:153902;
   • CLIC5: Chloride intracellular channel 5
     evidenced by: QTL:176054;
   • CLU: Clusterin
     evidenced by: QTL:18797;
   • CNNM2: Cyclin and CBS domain divalent metal cation transport mediator 2
     evidenced by: QTL:176077;
   • CNPY3: Canopy FGF signaling regulator 3
     evidenced by: QTL:176055;
   • CNTNAP2: Contactin associated protein 2
     evidenced by: QTL:315291;
   • COL22A1: Collagen type XXII alpha 1 chain
     evidenced by: QTL:174638; QTL:174639; QTL:174640;
   • COL24A1: Collagen, type XXIV, alpha 1
     evidenced by: QTL:174374; QTL:174375;
   • COL4A4: Collagen type IV alpha 4 chain
     evidenced by: QTL:39575;
   • CORO1C: Coronin 1C
     evidenced by: QTL:156722; QTL:168323;
   • CPSF1: Cleavage and polyadenylation specific factor 1, 160kDa
     evidenced by: QTL:57243;
   • CRACR2A: Calcium release activated channel regulator 2A
     evidenced by: QTL:175944;
   • CSAD: Cysteine sulfinic acid decarboxylase
     evidenced by: QTL:175945;
   • CSGALNACT1: Chondroitin sulfate N-acetylgalactosaminyltransferase 1
     evidenced by: QTL:53592;
   • CSN1S1: Casein alpha s1
     evidenced by: QTL:296791; QTL:3855;
   • CSN1S2: Casein alpha-S2
     evidenced by: QTL:296792;
   • CSN2: Casein beta
     evidenced by: QTL:10468; QTL:13558; QTL:136210; QTL:31638;
   • CSN3: Casein kappa
     evidenced by: QTL:10465; QTL:13567; QTL:136215; QTL:136220; QTL:21193; QTL:296793; QTL:296794; QTL:296795; QTL:296796; QTL:296797;
   • CTNNA3: Catenin alpha 3
     evidenced by: QTL:53763;
   • CXCR1: Chemokine (C-X-C motif) receptor 1
     evidenced by: QTL:20072; QTL:31620;
   • CXCR1: Chemokine (C-X-C motif) receptor 1
     evidenced by: QTL:283199; QTL:283198; QTL:283200;
   • CXCR2: C-X-C motif chemokine receptor 2
     evidenced by: QTL:263442; QTL:263445; QTL:263447; QTL:263449;
   • CYHR1: Cysteine and histidine rich 1
     evidenced by: QTL:161653; QTL:166923; QTL:174535;
   • CYP27A1: Cytochrome P450, family 27, subfamily A, polypeptide 1
     evidenced by: QTL:16146;
   • CYP7A1: Cytochrome P450, family 7, subfamily A, polypeptide 1
     evidenced by: QTL:296672; QTL:296675; QTL:296678; QTL:296681; QTL:296684; QTL:296703; QTL:296706; QTL:296709; QTL:296712;
   • CYP7B1: Cytochrome P450, family 7, subfamily B, polypeptide 1
     evidenced by: QTL:18843; QTL:18854;
   • DAB2: DAB2, clathrin adaptor protein
     evidenced by: QTL:174755; QTL:176007;
   • DACH1: Dachshund family transcription factor 1
     evidenced by: QTL:46327;
   • DCK: Deoxycytidine kinase
     evidenced by: QTL:174458;
   • DCUN1D1: Defective in cullin neddylation 1 domain containing 1
     evidenced by: QTL:38494;
   • DDIT3: DNA damage inducible transcript 3
     evidenced by: QTL:168866; QTL:168869;
   • DENND3: DENN domain containing 3
     evidenced by: QTL:174601;
   • DGAT1: Diacylglycerol O-acyltransferase 1
     evidenced by: QTL:101365; QTL:10260; QTL:10399; QTL:10404; QTL:10577; QTL:10579; QTL:10580; QTL:10585; QTL:121759; QTL:121764; QTL:12213; QTL:126964; QTL:126965; QTL:126966; QTL:130481; QTL:130540; QTL:156718; QTL:161649; QTL:166918; QTL:174537; QTL:181810; QTL:181811; QTL:18997; QTL:20076; QTL:20077; QTL:214754; QTL:214835; QTL:214838; QTL:223317; QTL:223319; QTL:24989; QTL:31658; QTL:31663; QTL:3507; QTL:3512; QTL:36308; QTL:4581; QTL:47448; QTL:65681; QTL:9977;
   • DGKG: Diacylglycerol kinase gamma
     evidenced by: QTL:136179;
   • DNAJC21: DnaJ heat shock protein family (Hsp40) member C21
     evidenced by: QTL:174779;
   • DNAJC5: DnaJ heat shock protein family (Hsp40) member C5
     evidenced by: QTL:174513;
   • DOCK1: Dedicator of cytokinesis 1
     evidenced by: QTL:315281;
   • DOCK5: Dedicator of cytokinesis 5
     evidenced by: QTL:43686;
   • DPP10: Dipeptidyl peptidase like 10
     evidenced by: QTL:175926;
   • DPYD: Dihydropyrimidine dehydrogenase
     evidenced by: QTL:174354; QTL:174355;
   • DZIP3: DAZ interacting zinc finger protein 3
     evidenced by: QTL:57245;
   • EBF1: EBF transcription factor 1
     evidenced by: QTL:43249;
   • EEF1D: Eukaryotic translation elongation factor 1 delta
     evidenced by: QTL:174555;
   • EFNA1: Ephrin A1
     evidenced by: QTL:174349;
   • EGFLAM: EGF like, fibronectin type III and laminin G domains
     evidenced by: QTL:174760; QTL:174761; QTL:174762; QTL:174763; QTL:176008;
   • ELOVL6: ELOVL fatty acid elongase 6
     evidenced by: QTL:161545; QTL:161546; QTL:161547; QTL:161550;
   • EMB: Embigin
     evidenced by: QTL:174700;
   • EPHA5: EPH receptor A5
     evidenced by: QTL:174430;
   • EPPK1: Epiplakin 1
     evidenced by: QTL:174548;
   • EPS8: Epidermal growth factor receptor pathway substrate 8
     evidenced by: QTL:174410; QTL:24991;
   • ERBB2: Erb-b2 receptor tyrosine kinase 2
     evidenced by: QTL:167459; QTL:167464;
   • ERC1: ELKS/RAB6-interacting/CAST family member 1
     evidenced by: QTL:175946; QTL:175947; QTL:175948; QTL:175949;
   • ERC2: ELKS/RAB6-interacting/CAST family member 2
     evidenced by: QTL:176051;
   • FABP4: Fatty acid binding protein 4, adipocyte
     evidenced by: QTL:102198; QTL:102199; QTL:102200; QTL:102206; QTL:136244;
   • FADS2: Fatty acid desaturase 2
     evidenced by: QTL:256849; QTL:256854; QTL:256855; QTL:256857; QTL:256858; QTL:256863; QTL:256867; QTL:256871; QTL:256872; QTL:256878; QTL:256882; QTL:256889; QTL:256898; QTL:256905; QTL:256912; QTL:256920; QTL:256923; QTL:256926; QTL:256931;
   • FAM134B: Family with sequence similarity 134 member B
     evidenced by: QTL:50912;
   • FAM135B: Family with sequence similarity 135 member B
     evidenced by: QTL:174642; QTL:174643; QTL:174644; QTL:174645; QTL:174646; QTL:174647; QTL:218662;
   • FAM13A: Family with sequence similarity 13, member A
     evidenced by: QTL:10495;
   • FASN: Fatty acid synthase
     evidenced by: QTL:28088; QTL:28093;
   • FBLN5: Fibulin 5
     evidenced by: QTL:125130;
   • FBXL6: F-box and leucine-rich repeat protein 6
     evidenced by: QTL:65679;
   • FBXO11: F-box protein 11
     evidenced by: QTL:218656;
   • FCGR2: Fc fragment of IgG, low affinity IIb, receptor (CD32)
     evidenced by: QTL:172726;
   • FCHSD2: FCH and double SH3 domains 2
     evidenced by: QTL:174679; QTL:174680;
   • FGF2: Fibroblast growth factor 2 (basic)
     evidenced by: QTL:136249;
   • FHIT: Fragile histidine triad diadenosine triphosphatase
     evidenced by: QTL:51723;
   • FOXA3: Forkhead box A3
     evidenced by: QTL:125128;
   • FOXF2: Forkhead box F2
     evidenced by: QTL:65673;
   • FRS2: Fibroblast growth factor receptor substrate 2
     evidenced by: QTL:174402;
   • FUT10: Fucosyltransferase 10
     evidenced by: QTL:53467;
   • GABARAPL1: GABA(A) receptor-associated protein like 1
     evidenced by: QTL:16170;
   • GALE: UDP-galactose-4-epimerase
     evidenced by: QTL:263416; QTL:263420; QTL:263424; QTL:263428;
   • GALNT8: Polypeptide N-acetylgalactosaminyltransferase 8
     evidenced by: QTL:174415;
   • GC: Group-specific component (vitamin D binding protein)
     evidenced by: QTL:174465; QTL:174466; QTL:175997;
   • GCM1: Glial cells missing homolog 1
     evidenced by: QTL:156726; QTL:168327;
   • GFRA2: GDNF family receptor alpha 2
     evidenced by: QTL:223328;
   • GH1: Growth hormone 1
     evidenced by: QTL:166801; QTL:166805;
   • GHR: Growth hormone receptor
     evidenced by: QTL:121742; QTL:121746; QTL:12862; QTL:12863; QTL:12864; QTL:12865; QTL:12866; QTL:12867; QTL:12868; QTL:174719; QTL:174720; QTL:174721; QTL:176009; QTL:176010; QTL:176011; QTL:176012; QTL:176013; QTL:181819; QTL:9980;
   • GLYCAM1: Glycosylation-dependent cell adhesion molecule 1
     evidenced by: QTL:175950;
   • GML: Glycosylphosphatidylinositol anchored molecule like
     evidenced by: QTL:174568; QTL:174569;
   • GNAS: GNAS complex locus
     evidenced by: QTL:16136;
   • GPM6B: Glycoprotein M6B
     evidenced by: QTL:55441;
   • GPR20: G protein-coupled receptor 20
     evidenced by: QTL:174596;
   • GPRIN2: G protein regulated inducer of neurite outgrowth 2
     evidenced by: QTL:315286; QTL:315292;
   • GRID2: Glutamate ionotropic receptor delta type subunit 2
     evidenced by: QTL:218643;
   • GUCA1A: Guanylate cyclase activator 1A
     evidenced by: QTL:176057;
   • GUCY2C: Guanylate cyclase 2C
     evidenced by: QTL:125120;
   • GYS2: Glycogen synthase 2
     evidenced by: QTL:174407;
   • HADHB: Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta
     evidenced by: QTL:296688; QTL:296690; QTL:296693; QTL:296695; QTL:296698; QTL:296700; QTL:296717;
   • HCN1: Hyperpolarization activated cyclic nucleotide gated potassium channel 1
     evidenced by: QTL:174701; QTL:174702; QTL:174703; QTL:174704; QTL:174705; QTL:174706; QTL:176014; QTL:176015; QTL:176016;
   • HIVEP3: HIVEP zinc finger 3
     evidenced by: QTL:175934;
   • HNF4G: Hepatocyte nuclear factor 4 gamma
     evidenced by: QTL:261834;
   • HOXC8: Homeobox C8
     evidenced by: QTL:175951;
   • HSD17B7: Hydroxysteroid (17-beta) dehydrogenase 7
     evidenced by: QTL:57247;
   • HSF1: Heat shock transcription factor 1
     evidenced by: QTL:223315; QTL:223320; QTL:223321; QTL:65687;
   • HSPA8: Heat shock protein family A (Hsp70) member 8
     evidenced by: QTL:167451; QTL:167454;
   • IDH1: Isocitrate dehydrogenase 1 (NADP+), soluble
     evidenced by: QTL:16151;
   • IDH2: Isocitrate dehydrogenase (NADP(+)) 2
     evidenced by: QTL:315649; QTL:315650; QTL:315655; QTL:315656; QTL:315660; QTL:315661; QTL:315668; QTL:315669; QTL:315676; QTL:315695; QTL:315696;
   • IFIH1: Interferon induced with helicase C domain 1
     evidenced by: QTL:16211;
   • IGF1: Insulin-like growth factor 1 (somatomedin C)
     evidenced by: QTL:13035; QTL:19049; QTL:19050;
   • IGF1R: Insulin-like growth factor 1 receptor
     evidenced by: QTL:122149; QTL:122150; QTL:122151; QTL:122152; QTL:122153; QTL:122154; QTL:122155; QTL:122156; QTL:122157; QTL:122158; QTL:122178; QTL:122179; QTL:122180; QTL:122181; QTL:122182; QTL:122183; QTL:122184; QTL:122185; QTL:122186; QTL:122187; QTL:122188; QTL:122189; QTL:122213; QTL:122214; QTL:122215; QTL:122216; QTL:122217; QTL:122218; QTL:122219; QTL:122220; QTL:122221; QTL:122222;
   • IGF2: Insulin-like growth factor 2 (somatomedin A)
     evidenced by: QTL:13043; QTL:13044;
   • IGFBP2: Insulin-like growth factor binding protein 2, 36kDa
     evidenced by: QTL:16216;
   • IGFBP7: Insulin-like growth factor binding protein 7
     evidenced by: QTL:16233;
   • IL12RB2: Interleukin 12 receptor, beta 2
     evidenced by: QTL:13222; QTL:13223;
   • IL20RA: Interleukin 20 receptor subunit alpha
     evidenced by: QTL:174502;
   • IL2: Interleukin 2
     evidenced by: QTL:18773; QTL:18775;
   • IL8: Interleukin 8
     evidenced by: QTL:15945; QTL:15947; QTL:263438;
   • INSIG1: Insulin induced gene 1
     evidenced by: QTL:181814;
   • IQANK1: IQ motif and ankyrin repeat containing 1
     evidenced by: QTL:174552;
   • IQSEC3: IQ motif and Sec7 domain 3
     evidenced by: QTL:175952;
   • IREB2: Iron responsive element binding protein 2
     evidenced by: QTL:218678;
   • IRF6: Interferon regulatory factor 6
     evidenced by: QTL:282807; QTL:282811; QTL:282814; QTL:282821; QTL:282825; QTL:282828; QTL:282836; QTL:282844; QTL:282852; QTL:282856; QTL:282861;
   • IRF9: Interferon regulatory factor 9
     evidenced by: QTL:16242;
   • ITGA1: Integrin subunit alpha 1
     evidenced by: QTL:174689; QTL:176017; QTL:176018;
   • ITGB1BP1: Integrin subunit beta 1 binding protein 1
     evidenced by: QTL:218657;
   • ITPR2: Inositol 1,4,5-trisphosphate receptor, type 2
     evidenced by: QTL:153903;
   • KCNA6: Potassium voltage-gated channel subfamily A member 6
     evidenced by: QTL:174413;
   • KCNIP4: Kv channel interacting protein 4
     evidenced by: QTL:41969;
   • KCNK9: Potassium two pore domain channel subfamily K member 9
     evidenced by: QTL:174624; QTL:174625;
   • KCNT1: Potassium sodium-activated channel subfamily T member 1
     evidenced by: QTL:46122;
   • KHDRBS3: KH domain containing, RNA binding, signal transduction associated 3
     evidenced by: QTL:174665; QTL:174666; QTL:174667; QTL:174668; QTL:218664;
   • KIF19: Kinesin family member 19
     evidenced by: QTL:153911;
   • KLF6: KLF transcription factor 6
     evidenced by: QTL:314333; QTL:314342; QTL:314350; QTL:314357; QTL:314361; QTL:314363; QTL:314368; QTL:314372; QTL:314376; QTL:314381; QTL:314385; QTL:314390; QTL:314393; QTL:314398; QTL:314403; QTL:314408; QTL:314411; QTL:314419;
   • KMT2D: Lysine methyltransferase 2D
     evidenced by: QTL:174377; QTL:174378;
   • LALBA: Lactalbumin, alpha-
     evidenced by: QTL:238151;
   • LAMA3: Laminin subunit alpha 3
     evidenced by: QTL:218683;
   • LAMA5: Laminin subunit alpha 5
     evidenced by: QTL:174520;
   • LAP3: Leucine aminopeptidase 3
     evidenced by: QTL:261792; QTL:261793; QTL:261797; QTL:261798;
   • LDHA: Lactate dehydrogenase A
     evidenced by: QTL:315680;
   • LDHB: Lactate dehydrogenase B
     evidenced by: QTL:315684; QTL:315687; QTL:315691;
   • LEP: Leptin
     evidenced by: QTL:10582; QTL:10583; QTL:13021; QTL:13022; QTL:13023; QTL:166800; QTL:18819; QTL:18821; QTL:31172; QTL:312624; QTL:31623; QTL:31627;
   • LETM1: Leucine zipper and EF-hand containing transmembrane protein 1
     evidenced by: QTL:42559;
   • LGMN: Legumain
     evidenced by: QTL:16193;
   • LHCGR: Luteinizing hormone/choriogonadotropin receptor
     evidenced by: QTL:285461;
   • LIN7A: Lin-7 homolog A, crumbs cell polarity complex component
     evidenced by: QTL:40757;
   • LIPA: Lipase A, lysosomal acid, cholesterol esterase
     evidenced by: QTL:16199;
   • LIPT2: Lipoyl(octanoyl) transferase 2
     evidenced by: QTL:47914;
   • LOC100140490: Transmembrane protease serine 11C
     evidenced by: QTL:174441;
   • LOC100140503: Alpha-fetoprotein-like
     evidenced by: QTL:174475;
   • LOC100296421: UDP-glucuronosyltransferase 2B4
     evidenced by: QTL:174448;
   • LOC100848939: Uncharacterized LOC100848939
     evidenced by: QTL:174572;
   • LOC101901918: Uncharacterized LOC101901918
     evidenced by: QTL:174589;
   • LOC101906736: Uncharacterized LOC101906736
     evidenced by: QTL:174478;
   • LOC104968898: Uncharacterized LOC104968898
     evidenced by: QTL:174479; QTL:174480;
   • LOC104973829: Uncharacterized LOC104973829
     evidenced by: QTL:174517;
   • LOC104975271: Uncharacterized LOC104975271
     evidenced by: QTL:174743;
   • LOC104975277: Uncharacterized LOC104975277
     evidenced by: QTL:174764; QTL:174765; QTL:176020;
   • LOC107132524: Uncharacterized LOC107132524
     evidenced by: QTL:175955;
   • LOC526979: UDP-glucuronosyltransferase 2C1
     evidenced by: QTL:174449;
   • LOC615278: E3 ubiquitin-protein ligase TRIM39
     evidenced by: QTL:174789;
   • LOC787628: Cytochrome P450 11B1, mitochondrial
     evidenced by: QTL:174567;
   • LPIN1: Lipin 1
     evidenced by: QTL:170543; QTL:170546; QTL:170550; QTL:170552; QTL:170555; QTL:170558; QTL:170562; QTL:170567; QTL:170572; QTL:170574;
   • LRBA: LPS responsive beige-like anchor protein
     evidenced by: QTL:48665;
   • LRP1: LDL receptor related protein 1
     evidenced by: QTL:175956;
   • LRRC8D: Leucine rich repeat containing 8 VRAC subunit D
     evidenced by: QTL:174365;
   • LTF: Lactotransferrin
     evidenced by: QTL:11616; QTL:166804; QTL:95721; QTL:95732; QTL:95734;
   • LY6E: Lymphocyte antigen 6 family member E
     evidenced by: QTL:174564;
   • MAF1: MAF1 homolog, negative regulator of RNA polymerase III
     evidenced by: QTL:174541;
   • MAGI1: Membrane associated guanylate kinase, WW and PDZ domain containing 1
     evidenced by: QTL:51649;
   • MALRD1: MAM and LDL receptor class A domain containing 1
     evidenced by: QTL:315278; QTL:315290;
   • MAML2: Mastermind like transcriptional coactivator 2
     evidenced by: QTL:181820;
   • MAML3: Mastermind like transcriptional coactivator 3
     evidenced by: QTL:48975;
   • MAP1B: Microtubule-associated protein 1B
     evidenced by: QTL:218676;
   • MAP4K4: Mitogen-activated protein kinase kinase kinase kinase 4
     evidenced by: QTL:130216; QTL:130219;
   • MAPK15: Mitogen-activated protein kinase 15
     evidenced by: QTL:174553;
   • MASP2: MBL associated serine protease 2
     evidenced by: QTL:314106; QTL:314107;
   • MAT2A: Methionine adenosyltransferase 2A
     evidenced by: QTL:261701; QTL:261704; QTL:261706;
   • MBP: Myelin basic protein
     evidenced by: QTL:218684;
   • MGP: Matrix Gla protein
     evidenced by: QTL:16175;
   • MOCS1: Molybdenum cofactor synthesis 1
     evidenced by: QTL:176058; QTL:52008;
   • MOXD1: Monooxygenase DBH like 1
     evidenced by: QTL:174492;
   • MPP7: Membrane palmitoylated protein 7
     evidenced by: QTL:156717; QTL:168320;
   • MROH1: Maestro heat-like repeat family member 1
     evidenced by: QTL:174538; QTL:174539; QTL:174540; QTL:65686;
   • MRPL32: Mitochondrial ribosomal protein L32
     evidenced by: QTL:16160;
   • MRTFA: Myocardin related transcription factor A
     evidenced by: QTL:214735;
   • MTG2: Mitochondrial ribosome associated GTPase 2
     evidenced by: QTL:174522;
   • MTMR12: Myotubularin related protein 12
     evidenced by: QTL:174787;
   • MTMR3: Myotubularin related protein 3
     evidenced by: QTL:16184;
   • MYBPC1: Myosin binding protein C, slow type
     evidenced by: QTL:40987;
   • MYH10: Myosin heavy chain 10
     evidenced by: QTL:215093;
   • NCF4: Neutrophil cytosolic factor 4
     evidenced by: QTL:174405;
   • NCKAP1L: NCK associated protein 1 like
     evidenced by: QTL:175957;
   • NCKAP5: NCK-associated protein 5
     evidenced by: QTL:175927;
   • NCOA1: Nuclear receptor coactivator 1
     evidenced by: QTL:45575;
   • NCSTN: Nicastrin
     evidenced by: QTL:39717;
   • NDUFA9: NADH:ubiquinone oxidoreductase subunit A9
     evidenced by: QTL:174416;
   • NDUFS4: NADH:ubiquinone oxidoreductase subunit S4
     evidenced by: QTL:174688;
   • NELL2: Neural EGFL like 2
     evidenced by: QTL:174386; QTL:174387; QTL:175958;
   • NGFR: Nerve growth factor receptor
     evidenced by: QTL:256277;
   • NIPBL: NIPBL, cohesin loading factor
     evidenced by: QTL:174769; QTL:174770; QTL:174771; QTL:176021; QTL:176023; QTL:176081;
   • NLRP9: NLR family, pyrin domain containing 9
     evidenced by: QTL:57248;
   • NNT: Nicotinamide nucleotide transhydrogenase
     evidenced by: QTL:174714; QTL:174715; QTL:176024;
   • NOD2: Nucleotide-binding oligomerization domain containing 2
     evidenced by: QTL:9986; QTL:9987;
   • NPFFR2: Neuropeptide FF receptor 2
     evidenced by: QTL:174471;
   • NPY: Neuropeptide Y
     evidenced by: QTL:18823;
   • NR4A1: Nuclear receptor subfamily 4 group A member 1
     evidenced by: QTL:169024; QTL:169027; QTL:169030; QTL:169035; QTL:169038; QTL:169043; QTL:169050; QTL:169053; QTL:169058; QTL:169060; QTL:169063; QTL:169066; QTL:169710; QTL:169714; QTL:175959;
   • NRG3: Neuregulin 3
     evidenced by: QTL:53823;
   • NRP1: Neuropilin 1
     evidenced by: QTL:315285;
   • NRSN2: Neurensin 2
     evidenced by: QTL:47329;
   • NSD2: Nuclear receptor binding SET domain protein 2
     evidenced by: QTL:42579;
   • NT5DC3: 5'-nucleotidase domain containing 3
     evidenced by: QTL:175960;
   • NUCB2: Nucleobindin 2
     evidenced by: QTL:176530; QTL:176536; QTL:176542; QTL:176547; QTL:176552; QTL:176558; QTL:176562; QTL:176567; QTL:176573; QTL:176579; QTL:176584;
   • OAS1Z: 2',5'-oligoadenylate synthetase 1, 40/46kDa
     evidenced by: QTL:16189;
   • OSBPL2: Oxysterol binding protein like 2
     evidenced by: QTL:174521;
   • OXCT1: 3-oxoacid CoA-transferase 1
     evidenced by: QTL:174729; QTL:174730; QTL:176025; QTL:176026;
   • PAEP: Progestagen-associated endometrial protein
     evidenced by: QTL:10463; QTL:12419; QTL:18886; QTL:238164; QTL:238171; QTL:31648; QTL:31650; QTL:31652;
   • PAIP1: Poly(A) binding protein interacting protein 1
     evidenced by: QTL:214854;
   • PAK5: P21 (RAC1) activated kinase 5
     evidenced by: QTL:46628;
   • PALLD: Palladin, cytoskeletal associated protein
     evidenced by: QTL:223324;
   • PARM1: Prostate androgen-regulated mucin-like protein 1
     evidenced by: QTL:57249;
   • PARP12: Poly (ADP-ribose) polymerase family, member 12
     evidenced by: QTL:16223;
   • PARP8: Poly(ADP-ribose) polymerase family member 8
     evidenced by: QTL:174699;
   • PCDHA13: Protocadherin alpha 13
     evidenced by: QTL:43048;
   • PCED1B: PC-esterase domain containing 1B
     evidenced by: QTL:175961;
   • PCIF1: Phosphorylated CTD interacting factor 1
     evidenced by: QTL:47372;
   • PDE1B: Phosphodiesterase 1B, calmodulin-dependent
     evidenced by: QTL:175962;
   • PDE9A: Phosphodiesterase 9A
     evidenced by: QTL:64786; QTL:64788; QTL:64790; QTL:64794; QTL:64797; QTL:64800; QTL:64803;
   • PEA15: Proliferation and apoptosis adaptor protein 15
     evidenced by: QTL:39732;
   • PEX2: Peroxisomal biogenesis factor 2
     evidenced by: QTL:18867;
   • PGLYRP1: Peptidoglycan recognition protein 1
     evidenced by: QTL:31023; QTL:31024; QTL:31026;
   • PHF20: PHD finger protein 20
     evidenced by: QTL:47339;
   • PHKA2: Phosphorylase kinase regulatory subunit alpha 2
     evidenced by: QTL:55219;
   • PIBF1: Progesterone immunomodulatory binding factor 1
     evidenced by: QTL:46359;
   • PIGN: Phosphatidylinositol glycan anchor biosynthesis class N
     evidenced by: QTL:52448;
   • PKD2: Polycystic kidney disease 2 (autosomal dominant)
     evidenced by: QTL:10483;
   • PKHD1: PKHD1, fibrocystin/polyductin
     evidenced by: QTL:223325; QTL:223326;
   • PKIA: Protein kinase (cAMP-dependent, catalytic) inhibitor alpha
     evidenced by: QTL:18868;
   • PKLR: Pyruvate kinase L/R
     evidenced by: QTL:261453; QTL:261454; QTL:261457; QTL:261461; QTL:261466; QTL:261471; QTL:261475; QTL:261481; QTL:261486; QTL:261491; QTL:261494; QTL:261499; QTL:261504; QTL:261509; QTL:261514; QTL:261518; QTL:261523; QTL:261527; QTL:261530; QTL:261535; QTL:261540; QTL:261545;
   • PLCB1: Phospholipase C beta 1
     evidenced by: QTL:46612;
   • PLEC: Plectin
     evidenced by: QTL:174546; QTL:261833;
   • PLEKHA5: Pleckstrin homology domain containing A5
     evidenced by: QTL:315294;
   • PLXNC1: Plexin C1
     evidenced by: QTL:175963;
   • PPARGC1A: Peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
     evidenced by: QTL:136188; QTL:20651; QTL:31632;
   • PPM1H: Protein phosphatase, Mg2+/Mn2+ dependent 1H
     evidenced by: QTL:175964;
   • PPME1: Protein phosphatase methylesterase 1
     evidenced by: QTL:156720; QTL:168321;
   • PPP1R16A: Protein phosphatase 1 regulatory subunit 16A
     evidenced by: QTL:174534;
   • PPP2R2B: Protein phosphatase 2 regulatory subunit Bbeta
     evidenced by: QTL:256264;
   • PRKDC: Protein kinase, DNA-activated, catalytic polypeptide
     evidenced by: QTL:174672; QTL:174673;
   • PRL: Prolactin
     evidenced by: QTL:11307;
   • PRLR: Prolactin receptor
     evidenced by: QTL:121755; QTL:16129; QTL:16130; QTL:166803; QTL:31678; QTL:5634; QTL:5635; QTL:95249;
   • PRMT8: Protein arginine methyltransferase 8
     evidenced by: QTL:175965;
   • PRNP: Prion protein
     evidenced by: QTL:1512; QTL:1523; QTL:3608; QTL:3609; QTL:3610; QTL:3633; QTL:2466; QTL:2694; QTL:1757; QTL:3732; QTL:3432;
   • PRPF6: Pre-mRNA processing factor 6
     evidenced by: QTL:174512;
   • PRPH: Peripherin
     evidenced by: QTL:174376;
   • PRRX2: Paired related homeobox 2
     evidenced by: QTL:46107;
   • PTBP2: Polypyrimidine tract binding protein 2
     evidenced by: QTL:39785;
   • PTK2: Protein tyrosine kinase 2
     evidenced by: QTL:174605; QTL:174606; QTL:174607; QTL:174608; QTL:71142; QTL:71148; QTL:71195; QTL:71199; QTL:71202; QTL:71205; QTL:71208; QTL:71211; QTL:71214; QTL:71217; QTL:71220; QTL:71223;
   • PTPRO: Protein tyrosine phosphatase, receptor type O
     evidenced by: QTL:174411;
   • PTPRR: Protein tyrosine phosphatase, receptor type R
     evidenced by: QTL:174393; QTL:174394; QTL:174395;
   • PUS7L: Pseudouridine synthase 7 like
     evidenced by: QTL:175966;
   • PXYLP1: 2-phosphoxylose phosphatase 1
     evidenced by: QTL:315287;
   • RAB11FIP3: RAB11 family interacting protein 3
     evidenced by: QTL:315288;
   • RAB3IP: RAB3A interacting protein
     evidenced by: QTL:174400;
   • RAI14: Retinoic acid induced 14
     evidenced by: QTL:174780; QTL:174781;
   • RASAL1: RAS protein activator like 1
     evidenced by: QTL:181817;
   • RASSF6: Ras association domain family member 6
     evidenced by: QTL:174476;
   • RBBP8NL: RBBP8 N-terminal like
     evidenced by: QTL:174519;
   • RBM47: RNA binding motif protein 47
     evidenced by: QTL:42035;
   • RETSAT: Retinol saturase
     evidenced by: QTL:172744;
   • RHPN1: Rhophilin Rho GTPase binding protein 1
     evidenced by: QTL:174558;
   • RICTOR: RPTOR independent companion of MTOR complex 2
     evidenced by: QTL:174758;
   • RNF10: Ring finger protein 10
     evidenced by: QTL:49401;
   • ROBO1: Roundabout, axon guidance receptor, homolog 1 (Drosophila)
     evidenced by: QTL:2501;
   • RPAP3: RNA polymerase II associated protein 3
     evidenced by: QTL:24993;
   • RPL23A: Ribosomal protein L23a
     evidenced by: QTL:168871; QTL:168875; QTL:168878; QTL:168884; QTL:168890; QTL:168894; QTL:168901; QTL:168904; QTL:168908; QTL:168913; QTL:168917; QTL:168921; QTL:168925; QTL:168928; QTL:168931; QTL:168936; QTL:168940; QTL:168944; QTL:169689; QTL:169692;
   • RUFY3: RUN and FYVE domain containing 3
     evidenced by: QTL:174456; QTL:174457;
   • RUNX2: RUNX family transcription factor 2
     evidenced by: QTL:176059;
   • SAA2: Serum amyloid A2
     evidenced by: QTL:138693; QTL:138695; QTL:138698; QTL:138700; QTL:138702; QTL:138704; QTL:139817; QTL:139820; QTL:139822; QTL:64987; QTL:64989; QTL:64994;
   • SCD: Stearoyl-CoA desaturase (delta-9-desaturase)
     evidenced by: QTL:11701; QTL:166799; QTL:301215; QTL:301217; QTL:301219; QTL:301221;
   • SCRIB: Scribbled planar cell polarity protein
     evidenced by: QTL:174551;
   • SCRT1: Scratch family zinc finger 1
     evidenced by: QTL:65683;
   • SEC13: SEC13 homolog, nuclear pore and COPII coat complex component
     evidenced by: QTL:263571; QTL:263575; QTL:263580; QTL:263583;
   • SEC23IP: SEC23 interacting protein
     evidenced by: QTL:53012;
   • SEC24D: SEC24 homolog D, COPII coat complex component
     evidenced by: QTL:41852;
   • SECISBP2: SECIS binding protein 2
     evidenced by: QTL:43753;
   • SELE: Selectin E
     evidenced by: QTL:135781;
   • SELL: Selectin L
     evidenced by: QTL:135779; QTL:135780;
   • SELP: Selectin P
     evidenced by: QTL:135775; QTL:135776; QTL:135777; QTL:135778;
   • SERPINA14: Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 14
     evidenced by: QTL:16196;
   • SERPINA5: Serpin family A member 5
     evidenced by: QTL:125131;
   • SERPINB5: Serpin family B member 5
     evidenced by: QTL:52456;
   • SESN2: Sestrin 2
     evidenced by: QTL:168956; QTL:168967; QTL:168968; QTL:168970; QTL:168972; QTL:168975; QTL:168977; QTL:168990; QTL:168992; QTL:168995; QTL:168998; QTL:169002; QTL:169005; QTL:169007; QTL:169011; QTL:169014; QTL:169018; QTL:169020; QTL:169699; QTL:169706; QTL:169708;
   • SHROOM2: Shroom family member 2
     evidenced by: QTL:55634;
   • SHROOM3: Shroom family member 3
     evidenced by: QTL:174484; QTL:174485;
   • SIRT1: Sirtuin 1
     evidenced by: QTL:314110; QTL:314111;
   • SLC17A9: Solute carrier family 17 member 9
     evidenced by: QTL:174516;
   • SLC22A7: Solute carrier family 22 member 7
     evidenced by: QTL:256213; QTL:256214; QTL:256218; QTL:256221; QTL:256224; QTL:256225; QTL:256229; QTL:256231; QTL:256272; QTL:256275;
   • SLC24A2: Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2
     evidenced by: QTL:218651; QTL:218652;
   • SLC25A21: Solute carrier family 25 member 21
     evidenced by: QTL:51285;
   • SLC27A1: Solute carrier family 27 (fatty acid transporter), member 1
     evidenced by: QTL:18738;
   • SLC38A1: Solute carrier family 38, member 1
     evidenced by: QTL:174381;
   • SLC39A14: Solute carrier family 39 member 14
     evidenced by: QTL:261832;
   • SLC45A4: Solute carrier family 45 member 4
     evidenced by: QTL:174599; QTL:174600;
   • SLC4A4: Solute carrier family 4 member 4
     evidenced by: QTL:174461; QTL:175998;
   • SLC51A: Solute carrier family 51 alpha subunit
     evidenced by: QTL:218636;
   • SLC52A2: Solute carrier family 52 (riboflavin transporter), member 2
     evidenced by: QTL:65680;
   • SLC6A13: Solute carrier family 6 member 13
     evidenced by: QTL:175967; QTL:175968; QTL:175969;
   • SLC8A1: Solute carrier family 8 (sodium/calcium exchanger), member 1
     evidenced by: QTL:45244; QTL:45252;
   • SLC8B1: Solute carrier family 8 member B1
     evidenced by: QTL:181816;
   • SMPD5: Sphingomyelin phosphodiesterase 5, pseudogene
     evidenced by: QTL:174543;
   • SOWAHB: Sosondowah ankyrin repeat domain family member B
     evidenced by: QTL:174487;
   • SPAG1: Sperm associated antigen 1
     evidenced by: QTL:174677; QTL:214760;
   • SPATS2: Spermatogenesis associated serine rich 2
     evidenced by: QTL:175970;
   • SPIDR: Scaffold protein involved in DNA repair
     evidenced by: QTL:174671;
   • SPOCK1: SPARC (osteonectin), cwcv and kazal like domains proteoglycan 1
     evidenced by: QTL:43012;
   • SPP1: Secreted phosphoprotein 1
     evidenced by: QTL:10395; QTL:10480; QTL:13169; QTL:166802; QTL:65674;
   • SRC: V-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
     evidenced by: QTL:13146;
   • SREBF1: Sterol regulatory element binding transcription factor 1
     evidenced by: QTL:25314; QTL:25315;
   • SSBP2: Single stranded DNA binding protein 2
     evidenced by: QTL:218645;
   • STAT1: Signal transducer and activator of transcription 1, 91kDa
     evidenced by: QTL:136183;
   • STAT5A: Signal transducer and activator of transcription 5A
     evidenced by: QTL:10267; QTL:10268; QTL:136255; QTL:18734; QTL:18798;
   • STAT5B: Signal transducer and activator of transcription 5B
     evidenced by: QTL:14140;
   • STMN2: Stathmin-like 2
     evidenced by: QTL:18882;
   • SUCLG2: Succinate-CoA ligase GDP-forming subunit beta
     evidenced by: QTL:51581;
   • SUPT3H: SPT3 homolog, SAGA and STAGA complex component
     evidenced by: QTL:176060; QTL:176061;
   • TAF4: TATA-box binding protein associated factor 4
     evidenced by: QTL:174523;
   • TANC2: Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2
     evidenced by: QTL:218670;
   • TANK: TRAF family member associated NFKB activator
     evidenced by: QTL:39344;
   • TBC1D9: TBC1 domain family member 9
     evidenced by: QTL:48963;
   • TBCD: Tubulin folding cofactor D
     evidenced by: QTL:50066;
   • TCF7L2: Transcription factor 7-like 2 (T-cell specific, HMG-box)
     evidenced by: QTL:10198;
   • TDRD1: Tudor domain containing 1
     evidenced by: QTL:153912;
   • TG: Thyroglobulin
     evidenced by: QTL:31670;
   • TGM2: Transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase)
     evidenced by: QTL:16180;
   • THRSP: Thyroid hormone responsive
     evidenced by: QTL:31687;
   • THSD7B: Thrombospondin type 1 domain containing 7B
     evidenced by: QTL:175928;
   • TLR4: Toll-like receptor 4
     evidenced by: QTL:136230; QTL:167137; QTL:167142; QTL:167147; QTL:256618;
   • TMCC3: Transmembrane and coiled-coil domain family 3
     evidenced by: QTL:175971; QTL:175972; QTL:175973;
   • TMEM249: Transmembrane protein 249
     evidenced by: QTL:65682;
   • TMPRSS11F: Transmembrane protease, serine 11F
     evidenced by: QTL:174442; QTL:174443; QTL:174444;
   • TNKS: Tankyrase
     evidenced by: QTL:181812;
   • TOM1L1: Arget of myb1 (chicken)-like 1
     evidenced by: QTL:65675;
   • TPD52L2: TPD52 like 2
     evidenced by: QTL:174514;
   • TPH1: Tryptophan hydroxylase 1
     evidenced by: QTL:31673;
   • TRAF3IP2: TRAF3 interacting protein 2
     evidenced by: QTL:43957;
   • TRAPPC9: Trafficking protein particle complex 9
     evidenced by: QTL:161654; QTL:174615; QTL:174616; QTL:174617; QTL:174618; QTL:174619; QTL:174620; QTL:174621; QTL:174622; QTL:174623;
   • TSNARE1: T-SNARE domain containing 1
     evidenced by: QTL:174582; QTL:174583; QTL:174584;
   • TSPAN11: Tetraspanin 11
     evidenced by: QTL:175974;
   • TTC33: Tetratricopeptide repeat domain 33
     evidenced by: QTL:174741;
   • TULP3: Tubby like protein 3
     evidenced by: QTL:174418;
   • TXNDC5: Thioredoxin domain containing 5
     evidenced by: QTL:65668;
   • UBOX5: U-box domain containing 5
     evidenced by: QTL:47172;
   • UGDH: UDP-glucose 6-dehydrogenase
     evidenced by: QTL:25190;
   • UGT1A6: UDP glucuronosyltransferase 1 family, polypeptide A6
     evidenced by: QTL:16156;
   • UGT2A1: UDP glucuronosyltransferase family 2 member A1 complex locus
     evidenced by: QTL:174451;
   • UGT2B10: UDP glucuronosyltransferase 2 family, polypeptide B10
     evidenced by: QTL:174447;
   • UHRF2: Ubiquitin like with PHD and ring finger domains 2
     evidenced by: QTL:43642;
   • USP24: Ubiquitin specific peptidase 24
     evidenced by: QTL:175935;
   • VANGL1: VANGL planar cell polarity protein 1
     evidenced by: QTL:174350;
   • VPS13B: Vacuolar protein sorting 13 homolog B (yeast)
     evidenced by: QTL:214844;
   • VPS28: VPS28, ESCRT-I subunit
     evidenced by: QTL:161657; QTL:166921; QTL:174536; QTL:47444;
   • VPS53: VPS53 subunit of GARP complex
     evidenced by: QTL:315276;
   • WDR17: WD repeat domain 17
     evidenced by: QTL:53304;
   • WNT10B: Wingless-type MMTV integration site family, member 10B
     evidenced by: QTL:174379;
   • YTHDF3: YTH domain family, member 3
     evidenced by: QTL:18865;
   • ZBP1: Z-DNA binding protein 1
     evidenced by: QTL:47299;
   • ZBTB46: Zinc finger and BTB domain containing 46
     evidenced by: QTL:174515;
   • ZBTB7A: Zinc finger and BTB domain containing 7A
     evidenced by: QTL:65690;
   • ZC3H3: Zinc finger CCCH-type containing 3
     evidenced by: QTL:174556; QTL:174557;
   • ZFAND3: Zinc finger AN1-type containing 3
     evidenced by: QTL:176062;
   • ZFHX4: Zinc finger homeobox 4
     evidenced by: QTL:125126;
   • ZKSCAN8: Zinc finger with KRAB and SCAN domains 8
     evidenced by: QTL:176063; QTL:52179;
   • ZNF16: Zinc finger protein 16
     evidenced by: QTL:174527; QTL:174528;
   • ZNF335: Zinc finger protein 335
     evidenced by: QTL:47386;
   • ZNF45: Zinc finger protein 45
     evidenced by: QTL:49795;
   • ZNF696: Zinc finger protein 696
     evidenced by: QTL:174560;
   2019 correlations are found involving Milk yield